annual shareholders equity:
$671.64M+$229.62M(+51.95%)Summary
- As of today (September 19, 2025), VRDN annual stockholders equity is $671.64 million, with the most recent change of +$229.62 million (+51.95%) on December 31, 2024.
- During the last 3 years, VRDN annual shareholders equity has risen by +$483.92 million (+257.80%).
- VRDN annual shareholders equity is now at all-time high.
Performance
VRDN Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$515.17M-$89.30M(-14.77%)Summary
- As of today (September 19, 2025), VRDN quarterly stockholders equity is $515.17 million, with the most recent change of -$89.30 million (-14.77%) on June 30, 2025.
- Over the past year, VRDN quarterly shareholders equity has dropped by -$14.17 million (-2.68%).
- VRDN quarterly shareholders equity is now -27.18% below its all-time high of $707.50 million, reached on September 30, 2024.
Performance
VRDN quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VRDN Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.0% | -2.7% |
| 3 y3 years | +257.8% | +263.1% |
| 5 y5 years | +4163.3% | +2333.4% |
VRDN Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +257.8% | -27.2% | +263.1% |
| 5 y | 5-year | at high | +4163.3% | -27.2% | +2348.3% |
| alltime | all time | at high | +2911.7% | -27.2% | +2256.7% |
VRDN Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $515.17M(-14.8%) |
| Mar 2025 | - | $604.47M(-10.0%) |
| Dec 2024 | $671.64M(+51.9%) | $671.64M(-5.1%) |
| Sep 2024 | - | $707.50M(+33.7%) |
| Jun 2024 | - | $529.34M(-9.1%) |
| Mar 2024 | - | $582.53M(+31.8%) |
| Dec 2023 | $442.02M(+11.9%) | $442.02M(+55.9%) |
| Sep 2023 | - | $283.58M(-10.2%) |
| Jun 2023 | - | $315.86M(-9.9%) |
| Mar 2023 | - | $350.55M(-11.3%) |
| Dec 2022 | $395.06M(+110.5%) | $395.06M(-3.4%) |
| Sep 2022 | - | $409.01M(+188.2%) |
| Jun 2022 | - | $141.90M(-14.8%) |
| Mar 2022 | - | $166.64M(-11.2%) |
| Dec 2021 | $187.72M(+56.4%) | $187.72M(-8.2%) |
| Sep 2021 | - | $204.59M(+106.8%) |
| Jun 2021 | - | $98.91M(-6.7%) |
| Mar 2021 | - | $106.00M(-11.7%) |
| Dec 2020 | $120.04M(+661.9%) | $120.04M(+470.5%) |
| Sep 2020 | - | $21.04M(-0.6%) |
| Jun 2020 | - | $21.17M(-21.6%) |
| Mar 2020 | - | $27.00M(+71.4%) |
| Dec 2019 | $15.75M | $15.75M(-32.0%) |
| Sep 2019 | - | $23.17M(-30.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $33.44M(-18.4%) |
| Mar 2019 | - | $40.96M(-20.2%) |
| Dec 2018 | $51.34M(+33.3%) | $51.34M(-15.4%) |
| Sep 2018 | - | $60.72M(-10.3%) |
| Jun 2018 | - | $67.67M(-6.9%) |
| Mar 2018 | - | $72.71M(+88.8%) |
| Dec 2017 | $38.51M(+155.8%) | $38.51M(-1.2%) |
| Sep 2017 | - | $38.98M(-5.7%) |
| Jun 2017 | - | $41.34M(-13.9%) |
| Mar 2017 | - | $47.99M(+218.8%) |
| Dec 2016 | $15.05M(+44.6%) | $15.05M(+221.3%) |
| Sep 2016 | - | $4.69M(-27.2%) |
| Jun 2016 | - | $6.44M(-22.8%) |
| Mar 2016 | - | $8.34M(-19.9%) |
| Dec 2015 | $10.41M(+73.8%) | $10.41M(-17.6%) |
| Sep 2015 | - | $12.63M(+15.4%) |
| Jun 2015 | - | $10.94M(-16.8%) |
| Mar 2015 | - | $13.15M(+119.5%) |
| Dec 2014 | $5.99M(-125.1%) | $5.99M(-20.4%) |
| Sep 2014 | - | $7.53M(-11.0%) |
| Jun 2014 | - | $8.46M(-135.4%) |
| Dec 2013 | -$23.89M(+11.4%) | -$23.89M(+11.4%) |
| Dec 2012 | -$21.44M | - |
| Dec 2012 | - | -$21.44M |
FAQ
- What is Viridian Therapeutics, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is Viridian Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of VRDN is $671.64M
What is the all time high annual shareholders equity for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual stockholders equity is $671.64M
What is Viridian Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, VRDN annual stockholders equity has changed by +$229.62M (+51.95%)
What is Viridian Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of VRDN is $515.17M
What is the all time high quarterly shareholders equity for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly stockholders equity is $707.50M
What is Viridian Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, VRDN quarterly stockholders equity has changed by -$14.17M (-2.68%)